Voyager Therapeutics, Inc. Business Operations Contracts & Agreements
5 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (2)
- Termination Agreements (1)
- Collaboration and License Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023 (Filed With SEC on March 7, 2023)
- Termination Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
- Amendment No. 1 to the Collaboration and License Agreement, by and between Voyager Therapeutics, Inc. and Neurocrine Biosciences, Inc., dated June 14, 2019 (Filed With SEC on August 9, 2019)
- VOYAGER THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2015)
- VOYAGER THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2015)
